Financials
Income statement
Fiscal date | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 |
---|---|---|---|---|
Total reported revenue | 6.0B | 6.0B | 6.2B | 6.0B |
Cost of revenue | 3.7B | 3.7B | 3.9B | 3.9B |
Gross profit | 2.3B | 2.2B | 2.2B | 2.1B |
Operating expense | ||||
Research & development | 769.7M | 711.0M | 713.2M | 720.6M |
Selling general and admin | 1.2B | 987.6M | 981.1M | 915.1M |
Other operating expenses | — | — | — | — |
Operating income | 257.6M | 515.1M | 498.4M | 415.5M |
Non operating interest income | ||||
Income | — | — | 1.9M | 18.7M |
Expense | — | — | — | — |
Other income expense | 36.3M | -177.1M | -251.3M | 72.1M |
Pretax income | 277.8M | 324.1M | 248.9M | 506.3M |
Tax provision | -1.6B | 43.0M | 59.0M | 35.5M |
Net income | 1.9B | 281.1M | 189.9M | 470.8M |
Basic EPS | — | 0.0 | 0.0 | 0.0 |
Diluted EPS | — | 0.0 | 0.0 | 0.0 |
Basic average shares | — | 2.7B | 2.7B | 2.7B |
Diluted average shares | — | 2.8B | 2.8B | 2.8B |
EBITDA | 170.2M | 799.8M | 787.1M | 678.8M |
Net income from continuing op. | 1.9B | 281.1M | 189.9M | 470.8M |
Minority interests | 21.4M | 2.6M | 5.4M | 1.2M |
Preferred stock dividends | — | — | — | — |